• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2300495 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.3) New Drug Application 2023-07-19 Zhejiang Tianyuan BIO-PHARMACEUTICAL Co Ltd view
CYSB2200019 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(原6) Supplementary Application 2022-01-20 Wuhan Institute of Biological Products Co Ltd view
CXSB2300113 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(原6) Supplementary Application 2023-10-18 view
CXSS2200011 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.2) New Drug Application 2022-02-09 Shenzhen Sanofi Pasteur Biological Products Co Ltd view
CYSB2400276 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2024-10-17 Changchun Lnstitute of Biological Products Co Ltd view
CXSL2400449 四价流感病毒裂解疫苗(MDCK细胞) influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(2.2) New Drug Application 2024-07-15 view
CXSL2300149 四价流感病毒裂解疫苗(MDCK细胞) influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(2.2) New Drug Application 2023-02-23 Beijing Institute of Biological Products Co Ltd view
CYSB2101042 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2021-04-19 Changchun Lnstitute of Biological Products Co Ltd view
CXSS2300060 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.3) New Drug Application 2023-07-26 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2200113 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2022-05-05 Beijing Kexing Biology Product Co Ltd view
CYSB2400214 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2024-08-13 Beijing Kexing Biology Product Co Ltd view
CXSS2400027 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.3) New Drug Application 2024-03-22 Jiangsu Kangrun Biotechnology Co Ltd view
CYSB2200112 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2022-05-05 Beijing Kexing Biology Product Co Ltd view
CXSL2101292 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.2) New Drug Application 2021-08-30 Jiangsu Kangrun Biotechnology Co Ltd view
CXSB2101046 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2021-09-16 Beijing Kexing Biology Product Co Ltd view
CYSB2300178 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2023-10-10 Shanghai Institute of Biological Products Co Ltd view
CXSS2200083 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.3) New Drug Application 2022-10-14 Aleph Biomedical Company Limited view
CYSB2400275 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2024-10-17 Changchun Lnstitute of Biological Products Co Ltd view
CYSB2400170 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2024-07-03 Changchun Lnstitute of Biological Products Co Ltd view
CXSL2300148 四价流感病毒裂解疫苗(MDCK细胞) influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(2.2) New Drug Application 2023-02-23 Beijing Institute of Biological Products Co Ltd view